The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

VOLUME 64 , ISSUE 2 ( April-June, 2022 ) > List of Articles

REVIEW ARTICLE

Approach to Optimal Oxygen Therapy in the Management of COVID-19 Patients during Pandemic: An Indian Perspective

Manisha Bhardwaj, Surender Kashyap

Keywords : Awareness, COVID-19, Crisis, Oxygen, Rationale, Solutions

Citation Information : Bhardwaj M, Kashyap S. Approach to Optimal Oxygen Therapy in the Management of COVID-19 Patients during Pandemic: An Indian Perspective. Indian J Chest Dis Allied Sci 2022; 64 (2):114-123.

DOI: 10.5005/jp-journals-11007-0016

License: CC BY-NC 4.0

Published Online: 08-07-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

Background: A sudden spike in positive cases in the second wave of COVID-19 pandemic took Government, Public, and Healthcare system by surprise in India. It was bigger and deadlier than the first wave. Unsupervised oxygen delivery practiced in oxygen buses and pandals by untrained individuals was a matter of concern and should have been discouraged. This resulted in wastage of oxygen which could have led to catastrophic consequences. Awareness about the optimal use of oxygen by identifying errors in prescribing/practicing oxygen therapy will go a long way in saving lives. This article provides a quick review of oxygen therapy with a focus on the rationale use of oxygen and plausible solutions to mitigate wastage in a resource-constrained scenario, such as the COVID-19 pandemic.


HTML PDF Share
  1. Coronavirus Outbreak in India - covid19india.org. [cited 2021 Aug 1]. Available from: https://www.covid19india.org/.
  2. Ministry of Health and Family Welfare, Government of India. Annual Report 2020-2021. Available from: mohwf.nic.in.
  3. Kapoor G, Hauck S, Sriram A, et al. State-wise estimates of current hospital beds, intensive care unit (ICU) beds and ventilators in India: are we prepared for a surge in COVID-19 hospitalizations? medRxiv 2020. DOI: 10.1101/2020.06.16.20132787.
  4. Bikkina S, Manda VK, Rao UVA. Medical oxygen supply during COVID-19: a study with specific reference to State of Andhra Pradesh, India. Mater Today Proc 2021. DOI: 10.1016/j.matpr.2021.01.196.
  5. Update on Medical Oxygen Availability, Delhi. 2021 [cited 2021 Oct 2]. Available from: https://pib.gov.in/PressReleasePage.aspx?PRID=1712123.
  6. Supreme Court of India. Supply of Oxygen. 2021 [cited 2021 Oct 2]. Available from: https://main.sci.gov.in/supremecourt/2021/11622/11622_2021_35_35_27915_Order_06-May-2021.pdf.
  7. O'Driscoll R. British Thoracic Society Emergency Oxygen Audit Report National Audit Period:15 August-1 November 2015; 2015.
  8. Mason RJ. Pathogenesis of COVID-19 from a cell biology perspective. Eur Respir J 2020;55(4):2000607. DOI: 10.1183/13993003.00607-2020.
  9. COVID-19 infection prevention and control guidance|WHO Western Pacific. [cited 2021 Aug 1]. Available from: https://www.who.int/westernpacific/emergencies/covid-19/technical-guidance/infection-prevention-control.
  10. Clinical management of COVID-19 patients: living guidance. [cited 2021 Oct 1]. Available from: https://app.magicapp.org/#/guideline/j1WBYn/rec/Lw7OXL (Accessed on 25 January 2021).
  11. Guan W, Ni Z, Hu Y, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–1720. DOI:10.1056/NEJMoa2002032.
  12. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. DOI: 10.1016/S0140-6736(20)30183-5.
  13. Dhont S, Derom E, Van Braeckel E, et al. The pathophysiology of ‘happy’ hypoxemia in COVID-19. Respir Res 2020;21(1):198. DOI: 10.1186/s12931-020-01462-5.
  14. Tobin MJ, Laghi F, Jubran A. Why COVID-19 silent hypoxemia is baffling to physicians. Am J Respir Crit Care Med 2020;202(3):356–360. DOI: 10.1164/rccm.202006-2157CP.
  15. Pilcher J, Cameron L, Braithwaite I, et al. Comparative audit of oxygen use in the prehospital setting in acute COPD exacerbation over 5 years. Emerg Med J 2015;32(3):234–238. DOI: 10.1136/emermed-2013-203094.
  16. Cousins JL, Wark PAB, McDonald VM. Acute oxygen therapy: a review of prescribing and delivery practices. Int J Chron Obstruct Pulmon Dis 2016;11:1067–1075. DOI: 10.2147/COPD.S103607.
  17. Hale KE, Gavin C, O'Driscoll BR. Audit of oxygen use in emergency ambulances and in a hospital emergency department. Emerg Med J 2008;25(11):773–776. DOI: 10.1136/emj.2008.059287.
  18. Cameron L, Pilcher J, Weatherall M, et al. The risk of serious adverse outcomes associated with hypoxaemia and hyperoxaemia in acute exacerbations of COPD. Postgrad Med J 2012;88(1046):684–689. DOI: 10.1136/postgradmedj-2012-130809.
  19. Gunathilake R, Lowe D, Wills J, et al. Implementation of a multicomponent intervention to optimise patient safety through improved oxygen prescription in a rural hospital. Aust J Rural Health 2014;22(6):328–333. DOI: 10.1111/ajr.12115.
  20. Wijesinghe M, Shirtcliffe P, Perrin K, et al. An audit of the effect of oxygen prescription charts on clinical practice. Postgrad Med J 2010;86(1012):89–93. DOI: 10.1136/pgmj.2009.087528.
  21. Heffner JE. The story of oxygen. Respir Care 2013;58(1):18–31. DOI: 10.4187/respcare.01831.
  22. O'Driscoll BR, Howard LS, Earis J, et al. BTS guidelines for oxygen use in healthcare. Thorax 2017;72(Suppl 1):43–45. DOI:10.1136/thoraxjnl-2016-209729:
  23. World Health Organization. Clinical Management of COVID-19 Patients: Living Guidance. Geneva: World Health Organization 2021;16:1–309.
  24. Sarkar M, Niranjan N, Banyal P. Mechanisms of hypoxemia. Lung India 2017;34(1):47–60. DOI: 10.4103/0970-2113.197116.
  25. Madan A. Correlation between the levels of SpO2 and PaO2. Lung India 2017;34(3):307–308. DOI: 10.4103/lungindia.lungindia_106_17.
  26. Pulse oximetry to detect early deterioration of patients with COVID-19 in primary and community care settings. Updated 29 January 2021. [cited 2021 Oct 2] Available from: https://www.england.nhs.uk/coronavirus/publication/pulse-oximetry-to-detect-early-deterioration-of-patients-with-covid-19-in-primary-and-community-care-settings/.
  27. Luks AM, Swenson ER. Pulse oximetry for monitoring patients with COVID-19 at home: potential pitfalls and practical guidance. Ann Am Thorac Soc 2020;17(9):1040–1046. DOI: 10.1513/AnnalsATS.202005-418FR.
  28. Sood P, Paul G, Puri S. Interpretation of arterial blood gas. Indian J Crit Care Med 2010;14(2):57–64. DOI: 10.4103/0972-5229.68215.
  29. Indian Medical Association Hospital Board of India. Industrial oxygen vs. medical oxygen.
  30. Health Product Policy and Standards. [cited 2021 Dec 10]. Available from: https://www.who.int/teams/health-product-and-policy-standards/access-to-assistive-technology-medical-devices/medical-devices/oxygen.
  31. Atlas G. A method to quickly estimate remaining time for an oxygen E-cylinder. Anesth Analg 2004;98(4):1190. DOI: 10.1213/01.ANE.0000107601.21502.0F.
  32. Bateman N, Leach R. ABC of oxygen: acute oxygen therapy. BMJ 1998;317(7161):798–801. DOI: 10.1136/bmj.317.7161.798.
  33. Hardavella G, Karampinis I, Frille A, et al. Oxygen devices and delivery systems. Breathe 2019;15(3):e108–e116. DOI: 10.1183/20734735.0204-2019.
  34. Batool S, Garg R. Appropriate use of oxygen delivery devices. Open Anesthesiol J 2017;11:35–38. DOI: 10.2174/1874321801711010035.
  35. Guy T, Créac'hcadec A, Ricordel C, et al. High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU. Eur Respir J 2020;56(5):2001154. DOI: 10.1183/13993003.01154-2020.
  36. Frat J-P, Thille AW, Mercat A. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015;372:2185–2196. DOI: 10.1056/NEJMoa1503326.
  37. Tran K, Cimon K, Severn M. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One 2012;7(4):e35797. DOI: 10.1371/journal.pone.0035797.
  38. Fink DL, Goldman NR, Cai J, et al. Ratio of oxygen saturation index to guide management of COVID-19 pneumonia. Ann Am Thorac Soc 2021;18(8):1426–1428. DOI: 10.1513/AnnalsATS.202008-934RL.
  39. Roca O, Caralt B, Messika J, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med 2019;199(11):1368–1376. DOI: 101164/rccm201803-0589OC.
  40. Ni Y-N, Luo J, Yu H, et al. The effect of high-flow nasal cannula in reducing the mortality and the rate of endotracheal intubation when used before mechanical ventilation compared with conventional oxygen therapy and noninvasive positive pressure ventilation: a systematic review and meta-analysis. Am J Emerg Med 2018;36(2):226–233. DOI: 10.1016/j.ajem.2017.07.083.
  41. Tan D, Walline JH, Ling B, et al. High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multicenter, randomized controlled trial. Crit Care 2020;24(1):489. DOI: 10.1186/s13054-020-03214-9.
  42. Ministry of Health and Family Welfare, Government of India. Clinical management protocol for COVID-19 (in adults) version 6. Updated 24.05.2021.
  43. Burns KEA, Adhikari NKJ, Keenan SP, et al. Use of non-invasive ventilation to wean critically ill adults off invasive ventilation: meta-analysis and systematic review. BMJ 2009;338:b1574. DOI: 10.1136/bmj.b1574.
  44. Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 2017;50:1602426. DOI: 10.1183/13993003.02426-2016.
  45. Fu Y, Guan L, Wu W, et al. Noninvasive ventilation in patients with COVID-19-related acute hypoxemic respiratory failure: a retrospective cohort study. Front Med 2021;8:638201. DOI: 10.3389/fmed.2021.638201.
  46. Surviving sepsis campaign guidelines on the management of adults with coronavirus disease 2019 (COVID-19) in the ICU recommendation chart: include first updates.
  47. Frey B, Shann F. Oxygen administration in infants. Arch Dis Child Fetal Neonatal Ed. 2003;88(2):F84–F88. DOI: 10.1136/fn.88.2.f84.
  48. Coghill M, Ambalavanan N, Chatburn RL, et al. Accuracy of a novel system for oxygen delivery to small children. Pediatrics 2011;128(2):e382–e387. DOI: 10.1542/peds.2010-3745.
  49. Mach WJ, Thimmesch AR, Pierce JT, et al. Consequences of hyperoxia and the toxicity of oxygen in the lung. Nurs Res Pract 2011;2011:260482. DOI: 10.1155/2011/260482.
  50. Cooper JS, Phuyal P, Shah N. Oxygen toxicity. Encycl Respir Med 2021; pp. 282–289.
  51. Wingelaar TT, van Ooij PJAM, van Hulst RA. Oxygen toxicity and special operations forces diving: hidden and dangerous. Front Psychol 2017;8:1263. DOI: 10.3389/fpsyg.2017.01263.
  52. Budinger GRS, Mutlu GM. Balancing the risks and benefits of oxygen therapy in critically III adults. Chest 2013;143(4):1151–1162. DOI: 10.1378/chest.12-1215.
  53. Guérin C, Reignier J, Richard J, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013;368(23):2159–2168. DOI: 10.1056/NEJMoa1214103.
  54. Caputo N, Strayer R, Levitan R. Early self-proning in awake, non-intubated patients in the emergency department: a single ED's experience during the COVID-19 pandemic. Acad Emerg Med 2020;27(5):375–378. DOI: 10.1111/acem.13994.
  55. Elharrar X, Trigui Y, Dols A-M, et al. Use of prone positioning in non-intubated patients with COVID-19 and hypoxemic acute respiratory failure. JAMA 2020;323(22):2336–2338. DOI: 10.1001/jama.2020. 8255.
  56. Sartini C, Tresoldi M, Scarpellini P, et al. Respiratory parameters in patients with COVID-19 after using noninvasive ventilation in the prone position outside the intensive care unit. JAMA 2020;323(22):2338–2340. DOI: 10.1001/jama.2020.7861.
  57. Ferrando C, Mellado-Artigas R, Gea A, et al. Awake prone positioning does not reduce the risk of intubation in COVID-19 treated with high-flow nasal oxygen therapy: a multicenter, adjusted cohort study. Crit Care 2020;24(1):597. DOI: 10.1186/s13054-020-03314-6.
  58. Sryma P, Mittal S, Mohan A, et al. Effect of proning in patients with COVID-19 acute hypoxemic respiratory failure receiving noninvasive oxygen therapy. Lung India 2021;38(Suppl 1):S6–S10. DOI: 10.4103/lungindia.lungindia_794_20.
  59. Ministry of Defence. DCGI approves anti-COVID drug developed by DRDO for emergency use, Delhi. 2021 [cited 2021 Oct 2]. Available from: https://pib.gov.in/PressReleasePage.aspx?PRID=1717007. (Accessed on May 9, 2021).
  60. DBT-BIRAC Supported ‘Virafin’ from Zydus Gets Emergency Nod For Treating Moderate COVID-19 Infections In Adults, Delhi. 2021 [cited 2021 Oct 2]. Available from: https://pib.gov.in/PressReleasePage.aspx?PRID=1713722.
  61. Gupta D, Agarwal R, Aggarwal A, et al. Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations. Lung India 2013;30:228–267. DOI: 104103/0970-2113.116248.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.